Liu Yan-Cun, Yu Mu-Ming, Chai Yan-Fen, Shou Song-Tao
Department of Emergency Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Front Immunol. 2017 Nov 21;8:1601. doi: 10.3389/fimmu.2017.01601. eCollection 2017.
Sialic acid-binding immunoglobulin-type lectins (Siglecs) are a group of cell surface transmembrane receptors expressed on immune cells, and regulate immune balance in inflammatory diseases. Sepsis is a life-threatened inflammatory syndrome induced by infection, and the pathogenesis of sepsis includes immune dysregulation, inflammation, and coagulation disorder. Here, we reviewed the various roles acted by Siglecs family in the pathogenesis of sepsis. Siglec-1, Siglec-5, and Siglec-14 play bidirectional roles through modulation of inflammation and immunity. Siglec-2 regulates the immune balance during infection by modulating B cell and T cell response. Siglec-9 helps endocytosis of toll-like receptor 4, regulates macrophages polarization, and inhibits the function of neutrophils during infection. Siglec-10 inhibits danger-associated molecular patterns induced inflammation, helps the initiation of antigen response by T cells, and decreases B-1a cell population to weaken inflammation. Regulating the Siglecs function in the different stages of sepsis holds great potential in the therapy of sepsis.
唾液酸结合免疫球蛋白样凝集素(Siglecs)是一类在免疫细胞上表达的细胞表面跨膜受体,可调节炎症性疾病中的免疫平衡。脓毒症是一种由感染引起的危及生命的炎症综合征,脓毒症的发病机制包括免疫失调、炎症和凝血障碍。在此,我们综述了Siglecs家族在脓毒症发病机制中所起的各种作用。Siglec-1、Siglec-5和Siglec-14通过调节炎症和免疫发挥双向作用。Siglec-2通过调节B细胞和T细胞反应来调节感染期间的免疫平衡。Siglec-9有助于Toll样受体4的内吞作用,调节巨噬细胞极化,并在感染期间抑制中性粒细胞的功能。Siglec-10抑制危险相关分子模式诱导的炎症,帮助T细胞启动抗原反应,并减少B-1a细胞群体以减轻炎症。在脓毒症的不同阶段调节Siglecs的功能在脓毒症治疗中具有巨大潜力。